SEC Form 4 · accession 0001179110-15-002374
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ambra Thomas E D Ph.D.
Director
Period of report
Feb 10, 2015
Accepted (ET)
Feb 12, 2015 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 10, 2015 | S | 20,000 | $16.91 | D | 2,651,712 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on May 9, 2014.